BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11418307)

  • 1. Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients.
    Birebent B; Somasundaram R; Purev E; Li W; Mitchell E; Hoey D; Bloom E; Mastrangelo M; Maguire H; Harris DT; Staib L; Braumuller H; Leeser C; Kuttner N; Beger HG; Herlyn D
    Crit Rev Oncol Hematol; 2001; 39(1-2):107-13. PubMed ID: 11418307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
    Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
    Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of recombinant GA733-2E antigen (CO17-1A, EGP, KS1-4, KSA, Ep-CAM) in gastro-intestinal carcinoma patients.
    Staib L; Birebent B; Somasundaram R; Purev E; Braumüller H; Leeser C; Küttner N; Li W; Zhu D; Diao J; Wunner W; Speicher D; Beger HG; Song H; Herlyn D
    Int J Cancer; 2001 Apr; 92(1):79-87. PubMed ID: 11279610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotype and recombinant antigen in immunotherapy of colorectal cancer.
    Herlyn D; Somasundaram R; Zaloudik J; Jacob L; Harris D; Kieny MP; Sears H; Mastrangelo M
    Cell Biophys; 1994; 24-25():143-53. PubMed ID: 7736518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice.
    Zaloudik J; Li W; Jacob L; Kieny MP; Somasundaram R; Acres B; Song H; Zhang T; Li J; Herlyn D
    Cancer Gene Ther; 2002 Apr; 9(4):382-9. PubMed ID: 11960289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector.
    Basak S; Eck S; Gutzmer R; Smith AJ; Birebent B; Purev E; Staib L; Somasundaram R; Zaloudik J; Li W; Jacob L; Mitchell E; Speicher D; Herlyn D
    Ann N Y Acad Sci; 2000 Jun; 910():237-52; discussion 252-3. PubMed ID: 10911917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients.
    Fagerberg J; Steinitz M; Wigzell H; Askelöf P; Mellstedt H
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4773-7. PubMed ID: 7539133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.
    Birebent B; Koido T; Mitchell E; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai E; Herlyn D
    J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R27-33. PubMed ID: 11768621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human colorectal cancer (CRC) antigen CO17-1A/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice.
    Li W; Berencsi K; Basak S; Somasundaram R; Ricciardi RP; Gönczöl E; Zaloudik J; Linnenbach A; Maruyama H; Miniou P; Herlyn D
    J Immunol; 1997 Jul; 159(2):763-9. PubMed ID: 9218593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
    Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
    J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloned antigens and antiidiotypes.
    Herlyn D; Somasundaram R; Zaloudik J; Li W; Jacob L; Harris D; Kieny MP; Ricciardi R; Gonczol E; Sears H
    Hybridoma; 1995 Apr; 14(2):159-66. PubMed ID: 7590774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients.
    Birebent B; Mitchell E; Akis N; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai D; Zhang T; Herlyn DM
    Vaccine; 2003 Apr; 21(15):1601-12. PubMed ID: 12639481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of an antigen homologous to the human CO17-1A/GA733 colon cancer antigen in animal tissues.
    Zaloudik J; Basak S; Nesbit M; Speicher DW; Wunner WH; Miller E; Ernst-Grotkowski C; Kennedy R; Bergsagel LP; Koido T; Herlyn D
    Br J Cancer; 1997; 76(7):909-16. PubMed ID: 9328151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue.
    Basak S; Speicher D; Eck S; Wunner W; Maul G; Simmons MS; Herlyn D
    J Natl Cancer Inst; 1998 May; 90(9):691-7. PubMed ID: 9586666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma.
    Mosolits S; Harmenberg U; Rudén U; Ohman L; Nilsson B; Wahren B; Fagerberg J; Mellstedt H
    Cancer Immunol Immunother; 1999 Feb; 47(6):315-20. PubMed ID: 10203061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of ELISA conditions to quantify colorectal cancer antigen-antibody complex protein (GA733-FcK) expressed in transgenic plant.
    Ahn J; Lee KJ; Ko K
    Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):1-7. PubMed ID: 24555929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinoma.
    Mellstedt H; Fagerberg J; Frödin JE; Hjelm-Skog AL; Liljefors M; Markovic K; Mosolits S; Ragnhammar P
    Ann N Y Acad Sci; 2000 Jun; 910():254-61; discussion 261-2. PubMed ID: 10911918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinoma.
    Mosolits S; Steinitz M; Harmenberg U; Ruden U; Eriksson E; Mellstedt H; Fagerberg J
    Cancer Immunol Immunother; 2002 Jun; 51(4):209-18. PubMed ID: 12012108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM).
    Chong JM; Speicher DW
    J Biol Chem; 2001 Feb; 276(8):5804-13. PubMed ID: 11080501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.